<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10217534" created="19/05/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10217534</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="cellular_disposition" sem="Other">Cellular disposition</term> of <term id="T2" lex="sulphamethoxazole" sem="Organic_compound_other">sulphamethoxazole</term> and its <term id="T3" lex="metabolite" sem="Organic_compound_other">metabolites</term>: <term id="T4" lex="implications_for_hypersensitivity" sem="Other">implications for hypersensitivity</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Physiological_process"/>
<theme idref="T2"/>
<clue><clueLoc>Cellular</clueLoc> <clueType>disposition</clueType> <linkTheme>of</linkTheme> sulphamethoxazole and its metabolites: implications for hypersensitivity.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Physiological_process"/>
<theme idref="T2" idref1="T3"/>
<clue><clueLoc>Cellular</clueLoc> <clueType>disposition</clueType> <linkTheme>of</linkTheme> sulphamethoxazole and <corefTheme>its metabolites</corefTheme>: implications for hypersensitivity.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Correlation"/>
<theme idref="E1"/>
<theme idref="T4"/>
<clue>Cellular disposition of sulphamethoxazole and its metabolites: <clueType>implications</clueType> <linkTheme>for</linkTheme> hypersensitivity.</clue>
</event>
<event KT="Investigation" id="E4">
<type class="Correlation"/>
<theme idref="E2"/>
<theme idref="T4"/>
<clue>Cellular disposition of sulphamethoxazole and its metabolites: <clueType>implications</clueType> <linkTheme>for</linkTheme> hypersensitivity.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">1. Bioactivation of <term id="T5" lex="sulphamethoxazole" sem="Organic_compound_other">sulphamethoxazole</term> (<term id="T6" lex="SMX" sem="Organic_compound_other">SMX</term>) to chemically-reactive <term id="T7" lex="metabolite" sem="Organic_compound_other">metabolites</term> and subsequent <term id="T8" lex="protein_conjugation" sem="Other"><term id="A101" sem="Protein_family_or_group">protein</term> conjugation</term> is thought to be involved in <term id="T9" lex="SMX_hypersensitivity" sem="Other"><term id="T10" lex="SMX" sem="Organic_compound_other">SMX</term> hypersensitivity</term>.</sentence>
<event KT="Fact" id="E5">
<type class="Metabolism"/>
<theme idref="T6"/>
<theme idref="T6" idref1="T7"/>
<clue>1. <clueType>Bioactivation</clueType> <linkTheme>of</linkTheme> sulphamethoxazole (SMX) <linkTheme>to</linkTheme> <corefTheme>chemically-reactive metabolites</corefTheme> and subsequent protein conjugation is thought to be involved in SMX hypersensitivity.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Binding"/>
<theme idref="T6" idref1="T7"/>
<theme idref="A101"/>
<clue>1. Bioactivation of sulphamethoxazole (SMX) to chemically-reactive metabolites and subsequent protein <clueType>conjugation</clueType> is thought to be involved in SMX hypersensitivity.</clue>
</event>
<event KT="Fact" id="E7">
<type class="Correlation"/>
<theme idref="E5"/>
<theme idref="T9"/>
<clue>1. Bioactivation of sulphamethoxazole (SMX) to chemically-reactive metabolites and subsequent protein conjugation is thought to be <clueType>involved</clueType> <linkTheme>in</linkTheme> SMX hypersensitivity.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Correlation"/>
<theme idref="E6"/>
<theme idref="T9"/>
<clue>1. Bioactivation of sulphamethoxazole (SMX) to chemically-reactive metabolites and subsequent protein conjugation is thought to be <clueType>involved</clueType> <linkTheme>in</linkTheme> SMX hypersensitivity.</clue>
</event>
<sentence id="S3">We have therefore examined the cellular metabolism, disposition and conjugation of <term id="T11" lex="SMX" sem="Organic_compound_other">SMX</term> and its <term id="T12" lex="metabolite" sem="Organic_compound_other">metabolites</term> in vitro.</sentence>
<event KT="Investigation" id="E201">
<type class="Metabolism"/>
<theme idref="T11"/>
<clue>We have therefore <clueKT>examined</clueKT> the cellular <clueType>metabolism</clueType>, disposition and conjugation <linkTheme>of</linkTheme> SMX and its metabolites in vitro.</clue>
</event>
<event KT="Investigation" id="E202">
<type class="Localization"/>
<theme idref="T11"/>
<clue>We have therefore <clueKT>examined</clueKT> the cellular metabolism, <clueType>disposition</clueType> and conjugation <linkTheme>of</linkTheme> SMX and its metabolites in vitro.</clue>
</event>
<event KT="Investigation" id="E203">
<type class="Binding"/>
<theme idref="T11"/>
<clue>We have therefore <clueKT>examined</clueKT> the cellular metabolism, disposition and <clueType>conjugation</clueType> <linkTheme>of</linkTheme> SMX and its metabolites in vitro.</clue>
</event>
<event KT="Investigation" id="E204">
<type class="Metabolism"/>
<theme idref="T11" idref1="T12"/>
<clue>We have therefore <clueKT>examined</clueKT> the cellular <clueType>metabolism</clueType>, disposition and conjugation <linkTheme>of</linkTheme> SMX and <corefTheme>its metabolites</corefTheme> in vitro.</clue>
</event>
<event KT="Investigation" id="E205">
<type class="Localization"/>
<theme idref="T11" idref1="T12"/>
<clue>We have therefore <clueKT>examined</clueKT> the cellular metabolism, <clueType>disposition</clueType> and conjugation <linkTheme>of</linkTheme> SMX and <corefTheme>its metabolites</corefTheme> in vitro.</clue>
</event>
<event KT="Investigation" id="E206">
<type class="Binding"/>
<theme idref="T11" idref1="T12"/>
<clue>We have therefore <clueKT>examined</clueKT> the cellular metabolism, disposition and <clueType>conjugation</clueType> <linkTheme>of</linkTheme> SMX and <corefTheme>its metabolites</corefTheme> in vitro.</clue>
</event>
<sentence id="S4">2. Flow cytometry revealed binding of <cons id="T13" lex="(AND N-hydroxy_(SMX-NHOH)_metabolite nitroso_(SMX-NO)_metabolite)" sem="(AND Organic_compound_other Organic_compound_other)"><frag id="F1"><term id="A1" lex="N-hydroxy (SMX-NHOH)" sem="Organic_compound_other">N-hydroxy (SMX-NHOH)</term></frag> and <frag id="F2"><term id="A2" lex="nitroso (SMX-NO)" sem="Organic_compound_other">nitroso (SMX-NO)</term></frag> <frag id="F3"><term id="A3" sem="Organic_compound_other">metabolites</term></frag></cons> <term id="A4" sem="Organic_compound_other">of <term id="T14" lex="SMX" sem="Organic_compound_other">SMX</term></term>, but not of <term id="T15" lex="SMX" sem="Organic_compound_other">SMX</term> itself, to the surface of viable <term id="T16" lex="white_blood_cell" sem="Cell_natural">white blood cells</term>.</sentence>
<event KT="Analysis" id="E9">
<type class="Cell_adhesion"/>
<theme idref="A1" idref1="A3" idref2="A4"/>
<theme idref="T16"/>
<clue>2. <clueExperiment>Flow cytometry</clueExperiment> <clueKT>revealed</clueKT> <clueType>binding</clueType> <linkTheme>of</linkTheme> N-hydroxy (SMX-NHOH) and nitroso (SMX-NO) metabolites of SMX, but not of SMX itself, <linkTheme>to</linkTheme> the surface of viable white blood cells.</clue>
</event>
<event KT="Analysis" id="E10">
<type class="Cell_adhesion"/>
<theme idref="A2" idref1="A3" idref2="A4"/>
<theme idref="T16"/>
<clue>2. <clueExperiment>Flow cytometry</clueExperiment> <clueKT>revealed</clueKT> <clueType>binding</clueType> <linkTheme>of</linkTheme> N-hydroxy (SMX-NHOH) and nitroso (SMX-NO) metabolites of SMX, but not of SMX itself, <linkTheme>to</linkTheme> the surface of viable white blood cells.</clue>
</event>
<sentence id="S5">Cellular haptenation by <term id="T17" lex="SMX-NO" sem="Organic_compound_other"><term id="T18" lex="SMX" sem="Organic_compound_other">SMX</term>-NO</term> was reduced by exogenous <term id="T19" lex="glutathione" sem="Peptide">glutathione</term> (<term id="T20" lex="GSH" sem="Peptide">GSH</term>).</sentence>
<event id="E11">
<type class="Physiological_process"/>
<cause idref="T17"/>
<clue><clueLoc>Cellular</clueLoc> <clueType>haptenation</clueType> <linkCause>by</linkCause> SMX-NO was reduced by exogenous glutathione (GSH).</clue>
</event>
<event id="E12">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="T20"/>
<clue>Cellular haptenation by SMX-NO was <clueType>reduced</clueType> <linkCause>by</linkCause> exogenous glutathione (GSH).</clue>
</event>
<sentence id="S6">3. <term id="T21" lex="SMX-NHOH" sem="Organic_compound_other"><term id="T22" lex="SMX" sem="Organic_compound_other">SMX</term>-NHOH</term> and <term id="T23" lex="SMX-NO" sem="Organic_compound_other"><term id="T24" lex="SMX" sem="Organic_compound_other">SMX</term>-NO</term> were rapidly reduced back to the parent compound by <term id="T25" lex="cysteine" sem="Amino_acid_monomer">cysteine</term> (<term id="T26" lex="CYS" sem="Amino_acid_monomer">CYS</term>), <term id="T27" lex="GSH" sem="Peptide">GSH</term>, <term id="T28" lex="human_peripheral_blood_cell" sem="Cell_natural">human peripheral blood cells</term> and <term id="A5" sem="Body_region">plasma</term>, suggesting that this is an important and <term id="T29" lex="ubiquitous_bioinactivation_mechanism" sem="Other"><term id="T30" lex="ubiquitous_protein" sem="Protein_family_or_group">ubiquitous</term> bioinactivation mechanism</term>.</sentence>
<event Manner="High" id="E13">
<type class="Metabolism"/>
<theme idref="T21"/>
<theme idref="T22"/>
<cause idref="T26"/>
<clue>3. SMX-NHOH and SMX-NO were <clueManner>rapidly</clueManner> <clueType>reduced back</clueType> <linkTheme>to</linkTheme> <corefTheme>the parent compound</corefTheme> <linkCause>by</linkCause> cysteine (CYS), GSH, human peripheral blood cells and plasma, suggesting that this is an important and ubiquitous bioinactivation mechanism.</clue>
</event>
<event Manner="High" id="E14">
<type class="Metabolism"/>
<theme idref="T21"/>
<theme idref="T22"/>
<cause idref="T27"/>
<clue>3. SMX-NHOH and SMX-NO were <clueManner>rapidly</clueManner> <clueType>reduced back</clueType> <linkTheme>to</linkTheme> <corefTheme>the parent compound</corefTheme> <linkCause>by</linkCause> cysteine (CYS), GSH, human peripheral blood cells and plasma, suggesting that this is an important and ubiquitous bioinactivation mechanism.</clue>
</event>
<event Manner="High" id="E15">
<type class="Metabolism"/>
<theme idref="T21"/>
<theme idref="T22"/>
<cause idref="T28"/>
<clue>3. SMX-NHOH and SMX-NO were <clueManner>rapidly</clueManner> <clueType>reduced back</clueType> <linkTheme>to</linkTheme> <corefTheme>the parent compound</corefTheme> <linkCause>by</linkCause> cysteine (CYS), GSH, human peripheral blood cells and plasma, suggesting that this is an important and ubiquitous bioinactivation mechanism.</clue>
</event>
<event Manner="High" id="E16">
<type class="Metabolism"/>
<theme idref="T21"/>
<theme idref="T22"/>
<cause idref="A5"/>
<clue>3. SMX-NHOH and SMX-NO were <clueManner>rapidly</clueManner> <clueType>reduced back</clueType> <linkTheme>to</linkTheme> <corefTheme>the parent compound</corefTheme> <linkCause>by</linkCause> cysteine (CYS), GSH, human peripheral blood cells and plasma, suggesting that this is an important and ubiquitous bioinactivation mechanism.</clue>
</event>
<sentence id="S7">4. <term id="T31" lex="fluorescence_HPLC" sem="Other">Fluorescence HPLC</term> showed that <term id="T32" lex="SMX-NHOH" sem="Organic_compound_other"><term id="T33" lex="SMX" sem="Organic_compound_other">SMX</term>-NHOH</term> and <term id="T34" lex="SMX-NO" sem="Organic_compound_other"><term id="T35" lex="SMX" sem="Organic_compound_other">SMX</term>-NO</term> depleted <term id="T36" lex="CYS" sem="Amino_acid_monomer">CYS</term> and <term id="T37" lex="GSH" sem="Peptide">GSH</term> in buffer, and to a lesser extent, in cells and <term id="T38" lex="plasma" sem="Tissue_natural">plasma</term>.</sentence>
<event KT="Analysis" id="E17">
<type class="Negative_regulation"/>
<theme idref="T36"/>
<cause idref="T32"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH <clueLoc>in buffer</clueLoc>, and to a lesser extent, in cells and plasma.</clue>
</event>
<event KT="Analysis" id="E117">
<type class="Negative_regulation"/>
<theme idref="T36"/>
<cause idref="T32"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH in buffer, and to a lesser extent, <clueLoc>in cells</clueLoc> and plasma.</clue>
</event>
<event KT="Analysis" id="E217">
<type class="Negative_regulation"/>
<theme idref="T36"/>
<cause idref="T32"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH in buffer, and to a lesser extent, <clueLoc>in</clueLoc> cells and <clueLoc>plasma</clueLoc>.</clue>
</event>
<event KT="Analysis" id="E18">
<type class="Negative_regulation"/>
<theme idref="T36"/>
<cause idref="T34"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH <clueLoc>in buffer</clueLoc>, and to a lesser extent, in cells and plasma.</clue>
</event>
<event KT="Analysis" id="E118">
<type class="Negative_regulation"/>
<theme idref="T36"/>
<cause idref="T34"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH in buffer, and to a lesser extent, <clueLoc>in cells</clueLoc> and plasma.</clue>
</event>
<event KT="Analysis" id="E218">
<type class="Negative_regulation"/>
<theme idref="T36"/>
<cause idref="T34"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH in buffer, and to a lesser extent, <clueLoc>in</clueLoc> cells and <clueLoc>plasma</clueLoc>.</clue>
</event>
<event KT="Analysis" id="E19">
<type class="Negative_regulation"/>
<theme idref="T37"/>
<cause idref="T32"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH <clueLoc>in buffer</clueLoc>, and to a lesser extent, in cells and plasma.</clue>
</event>
<event KT="Analysis" id="E119">
<type class="Negative_regulation"/>
<theme idref="T37"/>
<cause idref="T32"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH in buffer, and to a lesser extent, <clueLoc>in cells</clueLoc> and plasma.</clue>
</event>
<event KT="Analysis" id="E219">
<type class="Negative_regulation"/>
<theme idref="T37"/>
<cause idref="T32"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH in buffer, and to a lesser extent, <clueLoc>in</clueLoc> cells and <clueLoc>plasma</clueLoc>.</clue>
</event>
<event KT="Analysis" id="E20">
<type class="Negative_regulation"/>
<theme idref="T37"/>
<cause idref="T34"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH <clueLoc>in buffer</clueLoc>, and to a lesser extent, in cells and plasma.</clue>
</event>
<event KT="Analysis" id="E120">
<type class="Negative_regulation"/>
<theme idref="T37"/>
<cause idref="T34"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH in buffer, and to a lesser extent, <clueLoc>in cells</clueLoc> and plasma.</clue>
</event>
<event KT="Analysis" id="E220">
<type class="Negative_regulation"/>
<theme idref="T37"/>
<cause idref="T34"/>
<clue>4. <clueExperiment>Fluorescence HPLC</clueExperiment> <clueKT>showed</clueKT> that SMX-NHOH and SMX-NO <clueType>depleted</clueType> CYS and GSH in buffer, and to a lesser extent, <clueLoc>in</clueLoc> cells and <clueLoc>plasma</clueLoc>.</clue>
</event>
<sentence id="S8">5. <term id="T39" lex="neutrophil_apoptosis" sem="Other"><term id="A6" sem="Cell_natural">Neutrophil</term> apoptosis</term> and inhibition of <term id="T40" lex="neutrophil_function" sem="Other"><term id="A7" sem="Cell_natural">neutrophil</term> function</term> were induced at lower concentrations of <term id="T41" lex="SMX-NHOH" sem="Organic_compound_other"><term id="T42" lex="SMX" sem="Organic_compound_other">SMX</term>-NHOH</term> and <term id="T43" lex="SMX-NO" sem="Organic_compound_other"><term id="T44" lex="SMX" sem="Organic_compound_other">SMX</term>-NO</term> than those inducing loss of <term id="A8" sem="Other">membrane viability</term>, with <term id="T45" lex="SMX" sem="Organic_compound_other">SMX</term> having no effect.</sentence>
<event id="E21">
<type class="Cellular_physiological_process"/>
<theme idref="A6"/>
<clue>5. Neutrophil <clueType>apoptosis</clueType> and inhibition of neutrophil function were induced at lower concentrations of SMX-NHOH and SMX-NO than those inducing loss of membrane viability, with SMX having no effect.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="A7"/>
<clue>5. Neutrophil apoptosis and <clueType>inhibition</clueType> <linkTheme>of</linkTheme> neutrophil function were induced at lower concentrations of SMX-NHOH and SMX-NO than those inducing loss of membrane viability, with SMX having no effect.</clue>
</event>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<cause idref="T41"/>
<clue>5. Neutrophil apoptosis and inhibition of neutrophil function were <clueType>induced</clueType> <linkCause>at</linkCause> lower concentrations of SMX-NHOH and SMX-NO than those inducing loss of membrane viability, with SMX having no effect.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="E22"/>
<cause idref="T41"/>
<clue>5. Neutrophil apoptosis and inhibition of neutrophil function were <clueType>induced</clueType> <linkCause>at</linkCause> lower concentrations of SMX-NHOH and SMX-NO than those inducing loss of membrane viability, with SMX having no effect.</clue>
</event>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<cause idref="T43"/>
<clue>5. Neutrophil apoptosis and inhibition of neutrophil function were <clueType>induced</clueType> <linkCause>at</linkCause> lower concentrations of SMX-NHOH and SMX-NO than those inducing loss of membrane viability, with SMX having no effect.</clue>
</event>
<event id="E26">
<type class="Positive_regulation"/>
<theme idref="E22"/>
<cause idref="T43"/>
<clue>5. Neutrophil apoptosis and inhibition of neutrophil function were <clueType>induced</clueType> <linkCause>at</linkCause> lower concentrations of SMX-NHOH and SMX-NO than those inducing loss of membrane viability, with SMX having no effect.</clue>
</event>
<event KT="Other" id="E27">
<type class="Negative_regulation"/>
<theme idref="A8"/>
<clue>5. Neutrophil apoptosis and inhibition of neutrophil function were induced at lower concentrations of SMX-NHOH and SMX-NO than those inducing <clueType>loss</clueType> <linkTheme>of</linkTheme> membrane viability, with SMX having no effect.</clue>
</event>
<event KT="Fact" id="E28">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="T41"/>
<clue>5. Neutrophil apoptosis and inhibition of neutrophil function were induced at lower concentrations of SMX-NHOH and SMX-NO than <corefCause>those</corefCause> <clueType>inducing</clueType> loss of membrane viability, with SMX having no effect.</clue>
</event>
<event KT="Fact" id="E29">
<type class="Positive_regulation"/>
<theme idref="E27"/>
<cause idref="T43"/>
<clue>5. Neutrophil apoptosis and inhibition of neutrophil function were induced at lower concentrations of SMX-NHOH and SMX-NO than <corefCause>those</corefCause> <clueType>inducing</clueType> loss of membrane viability, with SMX having no effect.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E30">
<type class="Regulation"/>
<theme idref="E21"/>
<cause idref="T45"/>
<clue>5. Neutrophil apoptosis and inhibition of neutrophil function were induced at lower concentrations of SMX-NHOH and SMX-NO than those inducing loss of membrane viability, with SMX <clueType>having</clueType> <cluePolarity>no</cluePolarity> <clueType>effect</clueType>.</clue>
<comment>No corefTheme</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E31">
<type class="Regulation"/>
<theme idref="E22"/>
<cause idref="T45"/>
<clue>5. Neutrophil apoptosis and inhibition of neutrophil function were induced at lower concentrations of SMX-NHOH and SMX-NO than those inducing loss of membrane viability, with SMX <clueType>having</clueType> <cluePolarity>no</cluePolarity> <clueType>effect</clueType>.</clue>
<comment>No corefTheme</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E32">
<type class="Regulation"/>
<theme idref="E27"/>
<cause idref="T45"/>
<clue>5. Neutrophil apoptosis and inhibition of neutrophil function were induced at lower concentrations of SMX-NHOH and SMX-NO than those inducing loss of membrane viability, with SMX <clueType>having</clueType> <cluePolarity>no</cluePolarity> <clueType>effect</clueType>.</clue>
<comment>No corefTheme</comment></event>
<sentence id="S9"><term id="T46" lex="lymphocyte" sem="Cell_natural">Lymphocytes</term> were significantly (P&lt;0.05) more sensitive to the direct <term id="T47" lex="cytotoxic_effect" sem="Other">cytotoxic effects</term> of <term id="T48" lex="SMX-NO" sem="Organic_compound_other"><term id="T49" lex="SMX" sem="Organic_compound_other">SMX</term>-NO</term> than <term id="T50" lex="neutrophil" sem="Cell_natural">neutrophils</term>.</sentence>
<event Manner="High" id="E33">
<type class="Cellular_physiological_process"/>
<theme idref="T46"/>
<cause idref="T48"/>
<clue>Lymphocytes were <clueManner>significantly</clueManner> (P&lt;0.05) more <clueType>sensitive to</clueType> the direct <clueType>cytotoxic effects</clueType> <linkCause>of</linkCause> SMX-NO than neutrophils.</clue>
<comment>SENSITIVITY</comment></event>
<sentence id="S10">6. Partitioning of <term id="T51" lex="SMX-NHOH" sem="Organic_compound_other"><term id="T52" lex="SMX" sem="Organic_compound_other">SMX</term>-NHOH</term> into <term id="T53" lex="red_blood_cell" sem="Cell_natural">red blood cells</term> was significantly (P&lt;0.05) lower than with the <term id="A102" sem="Organic_compound_other"><term id="T54" lex="hydroxylamine" sem="Organic_compound_other">hydroxylamine</term> of <term id="T55" lex="dapsone" sem="Organic_compound_other">dapsone</term></term>.</sentence>
<event id="E101">
<type class="Localization"/>
<theme idref="T51"/>
<clue>6. <clueType>Partitioning</clueType> <linkTheme>of</linkTheme> SMX-NHOH <clueLoc>into red blood cells</clueLoc> was significantly (P&lt;0.05) lower than with the hydroxylamine of dapsone.</clue>
<comment>TPS T55</comment></event>
<event Manner="High" id="E102">
<type class="Negative_regulation"/>
<theme idref="E101"/>
<clue>6. Partitioning of SMX-NHOH into red blood cells was <clueManner>significantly</clueManner> (P&lt;0.05) <clueType>lower</clueType> than with the hydroxylamine of dapsone.</clue>
</event>
<event id="E103">
<type class="Localization"/>
<theme idref="A102"/>
<clue>6. <clueType>Partitioning</clueType> of SMX-NHOH <clueLoc>into red blood cells</clueLoc> was significantly (P&lt;0.05) lower than with the hydroxylamine of dapsone.</clue>
</event>
<sentence id="S11">7. Our results suggest that the balance between oxidation of <term id="T56" lex="SMX" sem="Organic_compound_other">SMX</term> to its toxic metabolites and their reduction is an important <term id="A9" sem="Other">protective cellular mechanism</term>.</sentence>
<event id="E34">
<type class="Metabolism"/>
<theme idref="T56"/>
<theme idref="T41"/>
<clue>7. Our results suggest that the balance between <clueType>oxidation</clueType> <linkTheme>of</linkTheme> SMX <linkTheme>to</linkTheme> <corefTheme>its toxic metabolites</corefTheme> and their reduction is an important protective cellular mechanism.</clue>
</event>
<event id="E35">
<type class="Metabolism"/>
<theme idref="T56"/>
<theme idref="T43"/>
<clue>7. Our results suggest that the balance between <clueType>oxidation</clueType> <linkTheme>of</linkTheme> SMX <linkTheme>to</linkTheme> <corefTheme>its toxic metabolites</corefTheme> and their reduction is an important protective cellular mechanism.</clue>
</event>
<event id="E36">
<type class="Metabolism"/>
<theme idref="T41"/>
<theme idref="T56"/>
<clue>7. Our results suggest that the balance between oxidation of SMX to its toxic metabolites and <corefTheme>their</corefTheme> <clueType>reduction</clueType> is an important protective cellular mechanism.</clue>
</event>
<event id="E37">
<type class="Metabolism"/>
<theme idref="T43"/>
<theme idref="T56"/>
<clue>7. Our results suggest that the balance between oxidation of SMX to its toxic metabolites and <corefTheme>their</corefTheme> <clueType>reduction</clueType> is an important protective cellular mechanism.</clue>
</event>
<event KT="Other" id="E38">
<type class="Regulation"/>
<theme idref="E35"/>
<theme idref="E37"/>
<clue>7. Our results suggest that the <clueType>balance</clueType> <linkTheme>between</linkTheme> oxidation of SMX to its toxic metabolites and their reduction is an important protective cellular mechanism.</clue>
</event>
<event KT="Other" id="E39">
<type class="Regulation"/>
<theme idref="E34"/>
<theme idref="E36"/>
<clue>7. Our results suggest that the <clueType>balance</clueType> <linkTheme>between</linkTheme> oxidation of SMX to its toxic metabolites and their reduction is an important protective cellular mechanism.</clue>
</event>
<event CL="L2" KT="Analysis" id="E40">
<type class="Correlation"/>
<theme idref="E38"/>
<theme idref="A9"/>
<clue>7. Our results <clueKT><clueCL>suggest</clueCL></clueKT> that the balance between oxidation of SMX to its toxic metabolites and their reduction <clueType>is</clueType> an important protective cellular mechanism.</clue>
</event>
<event CL="L2" KT="Analysis" id="E41">
<type class="Correlation"/>
<theme idref="E39"/>
<theme idref="A9"/>
<clue>7. Our results <clueKT><clueCL>suggest</clueCL></clueKT> that the balance between oxidation of SMX to its toxic metabolites and their reduction <clueType>is</clueType> an important protective cellular mechanism.</clue>
</event>
<sentence id="S12">If an imbalance exists, <term id="T57" lex="haptenation" sem="Other">haptenation</term> of the <term id="T58" lex="toxic_metabolite" sem="Organic_compound_other">toxic metabolites</term> to <term id="A10" sem="Protein_family_or_group">bodily proteins</term> including the surface of viable cells can occur, and may result in <term id="T59" lex="drug_hypersensitivity" sem="Other"><term id="A103" sem="Other">drug</term> hypersensitivity</term>.</sentence>
<event CL="L2" KT="Analysis" id="E42">
<type class="Physiological_process"/>
<theme idref="T41"/>
<theme idref="A10"/>
<clue>If an imbalance exists, <clueType>haptenation</clueType> <linkTheme>of</linkTheme> <corefTheme>the toxic metabolites</corefTheme> <linkTheme>to</linkTheme> bodily proteins including the surface of viable cells <clueKT><clueCL>can</clueCL></clueKT> <clueType>occur</clueType>, and may result in drug hypersensitivity.</clue>
</event>
<event CL="L2" KT="Analysis" id="E43">
<type class="Physiological_process"/>
<theme idref="T43"/>
<theme idref="A10"/>
<clue>If an imbalance exists, <clueType>haptenation</clueType> <linkTheme>of</linkTheme> <corefTheme>the toxic metabolites</corefTheme> <linkTheme>to</linkTheme> bodily proteins including the surface of viable cells <clueKT><clueCL>can</clueCL></clueKT> <clueType>occur</clueType>, and may result in drug hypersensitivity.</clue>
</event>
<event KT="Other" id="E104" uncertainty="probable">
<type/>
<cause idref="A103"/>
<clue>If an imbalance exists, haptenation of the toxic metabolites to bodily proteins including the surface of viable cells can occur, and may result in drug <clueType>hypersensitivity</clueType>.</clue>
<comment>SENSITIVITY</comment></event>
<event CL="L1" KT="Analysis" id="E44" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E104"/>
<cause idref="E43"/>
<clue>If an imbalance exists, haptenation of the toxic metabolites to bodily proteins including the surface of viable cells can occur, and <clueKT><clueCL>may</clueCL></clueKT> <clueType>result</clueType> <linkTheme>in</linkTheme> drug hypersensitivity.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
